NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

ASTHMAXcel Voice Study
ASTHMAXcel Voice Study

NCT06935084

RecruitingNA

Sponsor: Montefiore Medical Center

Conditions: Asthma

Interventions: ASTHMAXcel Voice platform

Countries: United States

The objective of this study is to conduct a randomized controlled trial (RCT) to compare the adapted and refined ASTHMAXcel Voice platform to usual care (UC). It is hypothesized by the investigator team that ASTHMAXcel Voice will be associated with improved clinical and process outcomes, asthma quality of life (QOL), medication adherence, and self-efficacy as compared to UC.

Eligibility overview

Sex: ALL

Age: 18 Years to

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

* English speaking
* Persistent asthma (diagnosed by a healthcare provider) on a daily controller medication
* Able to provide informed consent
* Smartphone access (iOS or Android) with data plan

Exclusion Criteria:

* Pregnancy
* Severe psychiatric or cognitive problems that would prohibit completion of protocol
Locations (1)
  • The Bronx, New York, United States